510(k) K820192
K820192 is an FDA 510(k) premarket notification submitted by Hyland Therapeutic Div., Travenol Laboratories for the device "HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM". The FDA issued a decision of Substantially Equivalent on Mar 11, 1982. The device falls under product code GRP (Antisera, All Types, H. Influenza), a Class II device regulated under 21 CFR 866.3300. Hyland Therapeutic Div., Travenol Laboratories has 43 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 11, 1982
- Date Received
- Jan 25, 1982
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antisera, All Types, H. Influenza
- Device Class
- Class II
- Regulation Number
- 866.3300
- Review Panel
- MI
- Submission Type
- 510(k) Exempt
Need the full FDA record for Hyland Therapeutic Div., Travenol Laboratories? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.